Compounds > g 1026
Page last updated: 2024-12-07

g 1026

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

G 1026: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133548
CHEMBL ID1632119
MeSH IDM0111416

Synonyms (8)

Synonym
benzamide, n-(4-chloro-3-(4-chlorobenzoyl)phenyl)-2-hydroxy-3,5-diiodo-
g-1026 ,
AKOS001482760
g 1026
80859-11-6
n-[4-chloro-3-(4-chlorobenzoyl)phenyl]-2-hydroxy-3,5-diiodobenzamide
CHEMBL1632119
DTXSID70230751
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID547928Antimicrobial activity against Pseudomonas aeruginosa ATCC 25619 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547942Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate NTUH4722 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID548647Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547926Antimicrobial activity against Bacillus subtilis ATCC 23857 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547932Antimicrobial activity against Mycobacterium smegmatis BCRC 11565 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547930Antimicrobial activity against Stenotrophomonas maltophilia ATCC 13637 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547927Antimicrobial activity against Escherichia coli ATCC 29213 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547925Antimicrobial activity against oxacillin- and methicillin-resistant Staphylococcus aureus isolate Sa-OXA-R2 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547943Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547929Antimicrobial activity against Acinetobacter baumannii ATCC 49139 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547931Antimicrobial activity against Serratia marcescens ATCC 14756 after 18 to 24 hrs by alamar blue assay2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
AID547935Inhibition of transglycosylase assessed as inhibition of NBD- labelled lipid II polymerization2010Bioorganic & medicinal chemistry, Dec-15, Volume: 18, Issue:24
High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index32.00 (26.88)
Search Engine Supply Index3.75 (0.95)

This Compound (23.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
3,3',4',5-tetrachlorosalicylanilide
3,3',4',5-tetrachlorosalicylanilide : A salicylanilide derivative with chloride substituents at C-3 and C-5 of the salicylate moiety and at C-3 and C-4 of the anilide moiety.		2.0510dichlorobenzene;
salicylanilides		drug allergen
ConditionIndicatedRelationship StrengthStudiesTrials
Infections, Staphylococcal
[description not available]		02.0510
Staphylococcal Infections
Infections with bacteria of the genus STAPHYLOCOCCUS.		02.0510
Cognitive Decline
[description not available]		02.1110
Cognitive Dysfunction
Diminished or impaired mental and/or intellectual function.		02.1110
Gender Dysphoria
A marked difference between the individual’s expressed/experienced gender and the gender others would assign to the individual, and it must continue for at least six months. (from DSM-5)		02.1310